Get Live Data

Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally
Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globallyView Video

Latest Share Chat

  2. Share Prices
  3. Astrazeneca Share Price
  4. Astrazeneca Share News
  5. UK dividends calendar - next 7 days

Pin to quick picksAstrazeneca Share News (AZN)

Astrazeneca Information

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,472.00
Bid: 12,492.00
Ask: 12,496.00
Change: 74.00 (0.60%)
Spread: 4.00 (0.032%)
Open: 12,432.00
High: 12,526.00
Low: 12,318.00
Prev. Close: 12,398.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK dividends calendar - next 7 days

Mon, 05th Sep 2022 15:50

Tuesday 6 September 
Royal Mail PLCdividend payment date
Wednesday 7 September 
ScotGems PLCdividend payment date
Thursday 8 September 
Assura PLCex-dividend date
Baltic Classifieds Group PLCex-dividend date
Braemar Shipping Services PLCex-dividend date
Camellia PLCex-dividend date
Chesnara PLCex-dividend date
CLS Holdings PLCex-dividend date
CRH PLCex-dividend date
Croda International PLCex-dividend date
CT Property Trust Ltdex-dividend date
Derwent London PLCex-dividend date
Develop North PLCex-dividend date
DWF Group PLCex-dividend date
GlobalData PLCex-dividend date
Grafton Group PLCex-dividend date
Greggs PLCex-dividend date
Harbour Energy PLCex-dividend date
Henderson Diversified Incomeex-dividend date
JPMorgan European Growth & Income PLCex-dividend date
Manolete Partners PLCex-dividend date
RELX PLCdividend payment date
Serco Group PLCex-dividend date
Severfield PLCex-dividend date
Temple Bar Investment Trust PLCex-dividend date
Uniphar PLCex-dividend date
VPC Specialty Lending Investments PLCex-dividend date
XP Power Ltdex-dividend date
Zotefoams PLCex-dividend date
Friday 9 September 
abrdn New Dawn Investment Trust PLCdividend payment date
Ashtead Group PLCdividend payment date
Berkeley Group Holdings PLCdividend payment date
Chemring Group PLCdividend payment date
Civitas Social Housing PLCdividend payment date
ContourGlobal PLCdividend payment date
Direct Line Insurance Group PLCdividend payment date
Home REIT PLCdividend payment date
Impact Healthcare REIT PLCdividend payment date
Informa PLCdividend payment date
Irish Residential Properties Reit PLCdividend payment date
Keller Group PLCdividend payment date
Man Group PLCdividend payment date
Monks Investment Trust PLCdividend payment date
Nichols PLCdividend payment date
Quartix Technologies PLCdividend payment date
Real Estate Credit Investments Ltddividend payment date
Residential Secure Income PLCdividend payment date
Tritax EuroBox PLCdividend payment date
Tyman PLCdividend payment date
Monday 12 September 
AstraZeneca PLCdividend payment date
BT Group PLCdividend payment date
Games Workshop Group PLCdividend payment date
Lloyds Banking Group PLCdividend payment date
LMS Capital PLCdividend payment date
Phoenix Group Holdings PLCdividend payment date
Rentokil Initial PLCdividend payment date
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
24 Oct 2023 17:08

LONDON MARKET CLOSE: FTSE 100 shakes off midday losses after US data

(Alliance News) - The FTSE 100 closed in the green on Tuesday following positive private sector data out of the US, despite figures closer to home showing a weaker UK private sector and rising unemployment.

Read more
24 Oct 2023 11:06

AstraZeneca says US accepts self-administered flu vaccine for review

(Alliance News) - AstraZeneca PLC on Tuesday said the US health watchdog has approved a review for its FluMist Quadrivalent self-administered flu vaccine, for which the drugmaker is seeking a green light.

Read more
23 Oct 2023 17:50

AstraZeneca celebrates drug trial results for cancer indications

(Alliance News) - AstraZeneca PLC on Monday said new drugs, developed in partnership with Daiichi Sankyo Co Ltd, showed positive results in patients with solid tumours, lung and breast cancer.

Read more
23 Oct 2023 17:08

LONDON MARKET CLOSE: Stocks largely down on Middle East hostilities

(Alliance News) - Stock prices in London closed largely lower on Monday, as investors were unable to shake off concerns surrounding the conflict in the Middle East, while developments in the US bond market added to the drama.

Read more
23 Oct 2023 08:45

TOP NEWS: AstraZeneca says Enhertu approved by European Commission

(Alliance News) - AstraZeneca PLC on Monday said its Enhertu treatment has been approved by the European Commission to treat adult lung cancer patients.

Read more
23 Oct 2023 07:46

LONDON BRIEFING: Keller expects higher profit; Upland rejects approach

(Alliance News) - Stocks in London are set to open slightly higher on Monday, as risk sentiment improves after a difficult period for markets last week.

Read more
18 Oct 2023 09:04

AstraZeneca drug Solaris approved in China as NMOSD treatment

(Alliance News) - AstraZeneca PLC on Wednesday announced that eculizumab, whose brand name is Solaris, has been approved in China to treat patients with neuromyelitis optica spectrum disorder

Read more
17 Oct 2023 12:06

LONDON MARKET MIDDAY: European markets uneasy but FTSE 100 outperforms

(Alliance News) - London's FTSE 100 higher was higher around midday, though it was defensive stocks such as utilities and pharmaceuticals which led the charge, suggesting there is still lingering discomfort in markets amid tensions in the Middle East.

Read more
16 Oct 2023 08:34

TOP NEWS: AstraZeneca's cancer drug gets priority review from US FDA

(Alliance News) - AstraZeneca PLC on Monday said that its new drug application for Tagrisso has been granted priority review in the US, after trial results extended progression-free survival.

Read more
4 Oct 2023 12:14

IN BRIEF: AstraZeneca's Forxiga drug shows positive results in trial

AstraZeneca PLC - Cambridge-based pharmaceutical maker - Says Forxiga drug meets primary endpoints in T2NOW phase three trial and shows "clinically meaningful" improvements in the glycaemic control among type two diabetes patients between the ages of 10 and 17. Adds safety results in patient cohort were consistent with those in adults with type two diabetes.

Read more
3 Oct 2023 16:55

LONDON MARKET CLOSE: Stocks red as rate rise fears continue to grow

(Alliance News) - Stocks in London were lower at the close on Tuesday after unexpectedly strong US job openings data added to fears that interest rates in the world's largest economy will stay higher for longer.

Read more
3 Oct 2023 11:59

LONDON MARKET MIDDAY: HSBC and StanChart help FTSE 100 outperform

(Alliance News) - London's FTSE 100 grew in confidence as Tuesday morning progressed, going into the afternoon in the green and outperforming European peers.

Read more
3 Oct 2023 08:36

TOP NEWS: AstraZeneca settles Nexium and Prilosec litigation

(Alliance News) - AstraZeneca PLC on Tuesday said it has settled legal matters involving its Nexium acid reflux and Prilosec heartburn products, parting with USD425 million.

Read more
3 Oct 2023 07:41

LONDON BRIEFING: Greggs sales rise; boohoo cuts revenue outlook

(Alliance News) - London's FTSE 100 is set to fall further on Tuesday, after a sell-off at the start of the week, with hawkish words from a US central banker reinforcing the 'higher-for-longer' interest rates messaging.

Read more
3 Oct 2023 07:24

AstraZeneca agrees to settle most Nexium, Prilosec claims

(Sharecast News) - Global pharmaceutical company AstraZeneca has agreed to settle litigation on product liability related to two of its widely-used heartburn drugs, Nexium and Prilosec, it announced on Tuesday.

Read more
141516171819202122

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.